These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17987223)

  • 1. Psychopathology of depression.
    Leonard BE
    Drugs Today (Barc); 2007 Oct; 43(10):705-16. PubMed ID: 17987223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression.
    Gao SF; Bao AM
    Neuroscientist; 2011 Feb; 17(1):124-44. PubMed ID: 20236945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional models of depression: from sub-types to substrates.
    Malhi GS; Parker GB; Greenwood J
    Acta Psychiatr Scand; 2005 Feb; 111(2):94-105. PubMed ID: 15667428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on neurobiological and psychological mechanisms underlying the anti-depressive effect of qigong exercise.
    Tsang HW; Fung KM
    J Health Psychol; 2008 Oct; 13(7):857-63. PubMed ID: 18809635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hypothalamic pituitary-adrenal axis dysfunction in the etiology of depressive disorders.
    McIsaac SA; Young AH
    Drugs Today (Barc); 2009 Feb; 45(2):127-33. PubMed ID: 19343232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indicators of the persistent pro-inflammatory activation of the immune system in depression].
    Cubała WJ; Godlewska B; Trzonkowski P; Landowski J
    Psychiatr Pol; 2006; 40(3):431-44. PubMed ID: 17037810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.
    Pucak ML; Carroll KA; Kerr DA; Kaplin AI
    Dialogues Clin Neurosci; 2007; 9(2):125-39. PubMed ID: 17726912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurobiological basis of mixed depression-anxiety states.
    Gulley LR; Nemeroff CB
    J Clin Psychiatry; 1993 Jan; 54 Suppl():16-9. PubMed ID: 8093884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do anxiety and depression have a common pathophysiological mechanism?
    Boyer P
    Acta Psychiatr Scand Suppl; 2000; (406):24-9. PubMed ID: 11131467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and epilepsy: A bidirectional relation?
    Kanner AM
    Epilepsia; 2011 Jan; 52 Suppl 1():21-7. PubMed ID: 21214536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine changes in depression.
    Joyce PR
    Aust N Z J Psychiatry; 1985 Jun; 19(2):120-7. PubMed ID: 2413836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test and response to somatic treatment: a review.
    Gitlin MJ; Gerner RH
    J Clin Psychiatry; 1986 Jan; 47(1):16-21. PubMed ID: 3510195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of depression.
    Rothschild AJ
    Med Clin North Am; 1988 Jul; 72(4):765-90. PubMed ID: 2897512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of depression].
    Tanabe A; Nomura S
    Nihon Rinsho; 2007 Sep; 65(9):1585-90. PubMed ID: 17876979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY; Lowy MT; Koenig JI
    Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.